Shusuan Jiang

546 total citations
27 papers, 213 citations indexed

About

Shusuan Jiang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Shusuan Jiang has authored 27 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 9 papers in Surgery. Recurrent topics in Shusuan Jiang's work include Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Shusuan Jiang is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Shusuan Jiang collaborates with scholars based in China, United States and Hong Kong. Shusuan Jiang's co-authors include Lin Qi, Long Wang, Wei He, Junjie Zhang, Lingxiao Chen, Zhenyu Ou, Ruizhe Wang, Ran Xu, Xiongbing Zu and Yu Xie and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Shusuan Jiang

25 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shusuan Jiang China 9 99 66 57 54 43 27 213
Binshen Chen China 8 87 0.9× 211 3.2× 65 1.1× 89 1.6× 44 1.0× 22 329
Liefu Ye China 10 141 1.4× 130 2.0× 24 0.4× 57 1.1× 50 1.2× 34 305
Sergio Serni Italy 10 152 1.5× 99 1.5× 26 0.5× 49 0.9× 35 0.8× 31 248
Mayuko Kanayama Japan 7 133 1.3× 47 0.7× 20 0.4× 51 0.9× 70 1.6× 16 202
Kara N. Babaian United States 8 232 2.3× 105 1.6× 18 0.3× 36 0.7× 40 0.9× 22 283
Anton Galich United States 7 121 1.2× 146 2.2× 64 1.1× 32 0.6× 71 1.7× 8 321
Hai Jiang China 8 39 0.4× 232 3.5× 31 0.5× 76 1.4× 46 1.1× 18 333
Claes Lindh Sweden 7 68 0.7× 72 1.1× 18 0.3× 18 0.3× 55 1.3× 12 213
Mahmut Akgül United States 7 115 1.2× 76 1.2× 10 0.2× 31 0.6× 26 0.6× 50 181
Lucas Regis Spain 11 323 3.3× 48 0.7× 52 0.9× 28 0.5× 37 0.9× 62 382

Countries citing papers authored by Shusuan Jiang

Since Specialization
Citations

This map shows the geographic impact of Shusuan Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shusuan Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shusuan Jiang more than expected).

Fields of papers citing papers by Shusuan Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shusuan Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shusuan Jiang. The network helps show where Shusuan Jiang may publish in the future.

Co-authorship network of co-authors of Shusuan Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Shusuan Jiang. A scholar is included among the top collaborators of Shusuan Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shusuan Jiang. Shusuan Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Bixia, Xinan Sheng, Shusuan Jiang, et al.. (2025). Nectin-4 targeted ADC, SHR-A2102, in patients with advanced or metastatic urothelial carcinoma: A phase 1 study.. Journal of Clinical Oncology. 43(5_suppl). 657–657. 2 indexed citations
2.
3.
4.
Huang, Liang, et al.. (2024). Insights into immune microenvironment and therapeutic targeting in androgen-associated prostate cancer subtypes. Scientific Reports. 14(1). 18036–18036. 4 indexed citations
5.
He, Zhisong, Mingjun Zhang, Shusuan Jiang, et al.. (2024). BGB-A317-212: A multicenter, open-label, phase II study to evaluate the efficacy and safety of tislelizumab in combination with lenvatinib in patients with selected solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2610–2610. 1 indexed citations
6.
Xie, Yu, et al.. (2024). Identification of the shared gene MXD3 signatures and biological mechanism in patients with hip pain and prostate cancer. Medicine. 103(37). e39592–e39592. 1 indexed citations
7.
Wang, Jing, Ning Li, Jin Zhang, et al.. (2024). A phase 1 study of HRS-1167 (M9466), a highly selective PARP1 inhibitor, in patients (pts) with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 3154–3154. 5 indexed citations
8.
Huang, Liang, et al.. (2022). A single‐centre, open‐label, single‐arm, fixed‐sequence pharmacokinetic study of SHR3680 on repaglinide and bupropion in prostate cancer patients. British Journal of Clinical Pharmacology. 89(2). 874–886. 3 indexed citations
9.
Huang, Liang, Yu Xie, Shusuan Jiang, et al.. (2022). Comprehensive Characterization of Ageing-Relevant Subtypes Associated With Different Tumorigenesis and Tumor Microenvironment in Prostate Cancer. Frontiers in Molecular Biosciences. 9. 803474–803474. 1 indexed citations
10.
11.
12.
Huang, Liang, Tao Dai, Longzheng Xia, et al.. (2021). SQLE Mediates Metabolic Reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer. OncoTargets and Therapy. Volume 14. 4285–4295. 14 indexed citations
13.
Cao, Jian, et al.. (2021). Correlation Between the Evolution of Somatic Alterations During Lymphatic Metastasis and Clinical Outcome in Penile Squamous Cell Carcinoma. Frontiers in Oncology. 11. 641869–641869. 2 indexed citations
14.
Wang, Yinhuai, et al.. (2020). Clinical Characterization of Mismatch Repair Gene-Deficient Metastatic Castration-Resistant Prostate Cancer. Frontiers in Oncology. 10. 533282–533282. 8 indexed citations
15.
Chen, Lingxiao, Zhenyu Ou, Mengda Zhang, et al.. (2019). Neoadjuvant Chemotherapy Benefits Survival in High-Grade Upper Tract Urothelial Carcinoma: A Propensity Score-Based Analysis. Annals of Surgical Oncology. 27(4). 1297–1303. 14 indexed citations
16.
Zhang, Junjie, Zhenyu Ou, Xiaobo Zhang, et al.. (2019). Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large-volume prostates > 80 ml: 18-month follow-up results. World Journal of Urology. 38(6). 1555–1562. 48 indexed citations
17.
Jiang, Shusuan, Sulai Liu, Yu Xie, et al.. (2015). Recurrent waist tumor subsequent to percutaneous nephrolithotomy: A case report. Oncology Letters. 10(1). 297–300.
18.
Liu, Sulai, Lin Qi, Xin-xing Wan, et al.. (2014). Overexpression of Wip1 Is Associated with Biologic Behavior in Human Clear Cell Renal Cell Carcinoma. PLoS ONE. 9(10). e110218–e110218. 17 indexed citations
19.
Liu, Sulai, et al.. (2014). Malignant priapism secondary to isolated penile metastasis from a renal pelvic carcinoma. Canadian Urological Association Journal. 8(7-8). 558–558. 5 indexed citations
20.
Liu, Sulai, Lin Qi, Qiuxia Yu, et al.. (2014). Survivin and HLA-I expression predicts survival of patients with clear cell renal cell carcinoma. Tumor Biology. 35(8). 8281–8288. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Binshen Chen Breakdown of academic impact, for papers by Liefu Ye Breakdown of academic impact, for papers by Sergio Serni Breakdown of academic impact, for papers by Mayuko Kanayama Breakdown of academic impact, for papers by Kara N. Babaian Breakdown of academic impact, for papers by Anton Galich Breakdown of academic impact, for papers by Hai Jiang Breakdown of academic impact, for papers by Claes Lindh Breakdown of academic impact, for papers by Mahmut Akgül Breakdown of academic impact, for papers by Lucas Regis
Rankless by CCL
2026